| COVID-19 vaccine development and a potential nanomaterial path forward MD Shin, S Shukla, YH Chung, V Beiss, SK Chan, OA Ortega-Rivera, ... Nature nanotechnology 15 (8), 646-655, 2020 | 674 | 2020 |
| Labeling live cells by copper-catalyzed alkyne− azide click chemistry V Hong, NF Steinmetz, M Manchester, MG Finn Bioconjugate chemistry 21 (10), 1912-1916, 2010 | 533 | 2010 |
| In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer PH Lizotte, AM Wen, MR Sheen, J Fields, P Rojanasopondist, ... Nature nanotechnology 11 (3), 295-303, 2016 | 456 | 2016 |
| Applications of viral nanoparticles in medicine I Yildiz, S Shukla, NF Steinmetz Current opinion in biotechnology 22 (6), 901-908, 2011 | 388 | 2011 |
| COVID-19 vaccine frontrunners and their nanotechnology design YH Chung, V Beiss, SN Fiering, NF Steinmetz ACS nano 14 (10), 12522-12537, 2020 | 372 | 2020 |
| Design of virus-based nanomaterials for medicine, biotechnology, and energy AM Wen, NF Steinmetz Chemical Society Reviews 45 (15), 4074-4126, 2016 | 367 | 2016 |
| The art of engineering viral nanoparticles JK Pokorski, NF Steinmetz Molecular pharmaceutics 8 (1), 29-43, 2011 | 331 | 2011 |
| Viral nanoparticles as platforms for next-generation therapeutics and imaging devices NF Steinmetz Nanomedicine: Nanotechnology, Biology and Medicine 6 (5), 634-641, 2010 | 318 | 2010 |
| Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications YH Chung, H Cai, NF Steinmetz Advanced Drug Delivery Reviews 156, 214-235, 2020 | 298 | 2020 |
| Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and-spheres in mice MA Bruckman, LN Randolph, A VanMeter, S Hern, AJ Shoffstall, ... Virology 449, 163-173, 2014 | 213 | 2014 |
| The impact of aspect ratio on the biodistribution and tumor homing of rigid soft‐matter nanorods S Shukla, FJ Eber, AS Nagarajan, NA DiFranco, N Schmidt, AM Wen, ... Advanced healthcare materials 4 (6), 874-882, 2015 | 199 | 2015 |
| Cpmv-dox delivers AAA Aljabali, S Shukla, GP Lomonossoff, NF Steinmetz, DJ Evans Molecular pharmaceutics 10 (1), 3-10, 2013 | 196 | 2013 |
| Built‐in active microneedle patch with enhanced autonomous drug delivery MA Lopez‐Ramirez, F Soto, C Wang, R Rueda, S Shukla, C Silva‐Lopez, ... Advanced Materials 32 (1), 1905740, 2020 | 191 | 2020 |
| Increased Tumor Homing and Tissue Penetration of the Filamentous Plant Viral Nanoparticle Potato virus X S Shukla, AL Ablack, AM Wen, KL Lee, JD Lewis, NF Steinmetz Molecular pharmaceutics 10 (1), 33-42, 2013 | 188 | 2013 |
| Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting FM Brunel, JD Lewis, G Destito, NF Steinmetz, M Manchester, ... Nano letters 10 (3), 1093-1097, 2010 | 185 | 2010 |
| Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles HS Leong, NF Steinmetz, A Ablack, G Destito, A Zijlstra, H Stuhlmann, ... Nature protocols 5 (8), 1406-1417, 2010 | 180 | 2010 |
| Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus MA Bruckman, K Jiang, EJ Simpson, LN Randolph, LG Luyt, X Yu, ... Nano letters 14 (3), 1551-1558, 2014 | 178 | 2014 |
| Virus-based nanoparticles as versatile nanomachines KJ Koudelka, AS Pitek, M Manchester, NF Steinmetz Annual review of virology 2 (1), 379-401, 2015 | 177 | 2015 |
| PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo NF Steinmetz, M Manchester Biomacromolecules 10 (4), 784-792, 2009 | 176 | 2009 |
| Utilisation of plant viruses in bionanotechnology NF Steinmetz, DJ Evans Organic & biomolecular chemistry 5 (18), 2891-2902, 2007 | 173 | 2007 |
